Detection and Characterisation Capability and Capacity for SARS-CoV-2 Variants Within the EU/EEA [open pdf - 678KB]
From the Key Messages: " In most Member States, the sequencing capacity for identification of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] variants is below the recommendation set by the European Commission to sequence 5-10% of SARS-CoV-2 positive specimens.  Although the majority of the EU/EEA [European Economic Area] countries are actively investigating the emergence of SARS-CoV-2 variants, three countries are not doing so.  Many countries are increasing or planning to increase their sequencing capacity but have indicated the need for support from ECDC [European Centre for Disease Prevention and Control].  Specific needs include support with sequencing capacities and protocols and with bioinformatics in particular.  For many countries, the turn-around time for PCR [polymerase chain reaction] pre-screening results shared with public health authorities is longer than 48 hours."
2021 European Centre for Disease Prevention and Control. Posted here with permission. Documents are for personal use only and not for commercial profit.
European Centre for Disease Prevention and Control: https://www.ecdc.europa.eu/